8
Funding Rounds
$92.7m
Money raised
Develops medicines for patients suffering from Alzheimer's disease and other neurological disorders.
Industries:
Key people:
- Martin Tolar ******.*****@alzheon.com
7
Funding Rounds
$189.5m
Money raised
Cerecin, formerly Accera, is a company that looks to develop therapeutic drugs for neurodegenerative diseases.
Industries:
1
Funding Rounds
Leucadia Therapeutics is a company working on Alzheimer's Disease.
Industries:
Location:
Key people:
5
Funding Rounds
$134.1m
Money raised
Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.
Industries:
Key people:
- Jason Chen *****@vergegenomics.com
- Alice Zhang *****@vergegenomics.com
3
Funding Rounds
$26.3m
Money raised
Creating a New Gold Standard in Brain Health With Precision Neurology.
Industries:
Location:
Key people:
- Adrian Locher **@alo.ag
- Ioannis Tarnanas *******.********@altoida.com
- Fabian Wahle linkedin
7
Funding Rounds
$14.1m
Money raised
Cytox Limited is a company founded in 2004 by Zsuzsanna Nagy.
Industries:
Location:
Key people:
4
Funding Rounds
$36.8m
Money raised
Neurotrack is a company offering a memory health tracking platform founded in 2012.
Industries:
Location:
2
Funding Rounds
$146.0m
Money raised
Muna develops transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases
Industries:
Location:
1
Funding Rounds
Avalon AI is a London-based developer of a deep learning-based diagnostics tool for the detection of brain degenerative diseases.
Industries:
Location:
2
Funding Rounds
$24.1m
Money raised
Optina Diagnostics develops technology for the early detection of disease through the eye.
Location:
1
Funding Rounds
$55.0m
Money raised
Linus Health is a company founded in 2019.
Industries:
Location:
4
Funding Rounds
$351.6m
Money raised
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions.
Industries:
Location:
3
Funding Rounds
$33.6m
Money raised
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
2
Funding Rounds
$40.4m
Money raised
Wren Therapeutics is a small Molecules Targeting Protein Mis-Folding founded in 2016 by Chris Dobson.
Industries:
Key people:
4
Funding Rounds
$12.3m
Money raised
Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS).
Industries:
Location:
3
Funding Rounds
$30.4m
Money raised
T3D Therapeutics is a company developing drug therapy for Alzheimer's disease founded by John Didsbury.
2
Funding Rounds
$147.5m
Money raised
Shape Therapeutics is a RNA-editing gene therapy.
Location:
3
Funding Rounds
$36.2m
Money raised
EIP Pharma is an alzheimer's treatment founded by Sylvie Gregoire.
Location:
Key people:
- John Alam *****@eippharma.com
- Sylvie Gregoire linkedin
1
Funding Rounds
$500.0k
Money raised
Neurodon is a biopharmaceutical company focusing on Alzheimer's disease founded by Russell Dahl.
Industries:
Location:
Key people:
3
Funding Rounds
$257.5m
Money raised
A company deveoping treatments for Alzheimer's disease and other neurological conditions
Location:
Key people:
1
Funding Rounds
$100.0m
Money raised
Asceneuron is a clinical-stage biotech company.
Industries:
Location:
2
Funding Rounds
$2.7m
Money raised
Cognos Therapeutics creates technologies to advance the diagnosis and treatment of neuropathic diseases.
Industries:
Location:
1
Funding Rounds
$14.5m
Money raised
reMYND is a preclinical In-Vivo Alzheimer's Contract Research.
Industries:
3
Funding Rounds
$99.1m
Money raised
Alternating Peptides for Neurological Diseases